Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 1 - 10 of about 975

Scientific:
   Adonis vernalis (oxeye daisy) 
   Bocconia frutescens (sea oxeye daisy) 
   Leucanthemum vulgare (oxeye daisy) 

Synonyms:
   Adonis vernalis (spring pheasant's eye) 
   Chrysanthemum leucanthemum (Common White Daisy) 
   Chrysanthemum leucanthemum pinnatifidum (oxeye daisy) 
   Chrysanthemum vulgare (tansy) 
   Chrysocyathus vernalis 
   Leucanthemum leucanthemum 
   Leucanthemum vulgare (oxeye-daisy) 
   Matricaria leucanthemum 
   Pyrethrum leucanthemum 
   Tanacetum leucanthemum 
   Tanacetum vulgare (garden tansy) 

Broader Terms:
   Adonis (Adonis) 
   Asterales 
   Chrysanthemum (daisy) 
   Leucanthemum (daisy) 
   Ranunculales 
   oxeye 

More Specific:
   Leucanthemum vulgare pujiulae 
 
 
Latest Articles on oxeye daisy from uBioRSS


Leucanthemum vulgare
ForestryImages.org

External Resources:

Did you mean: ox-eye daisy ?



1.  Modeling potential habitats and predicting habitat connectivity for Leucanthemum vulgare Lam. in northwestern rangelands of Iran.LinkIT
Khanghah SS, Moameri M, Ghorbani A, Mostafazadeh R, Biswas A
Environmental monitoring and assessment, 2022
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

2.  Phytochemical profiling and antioxidant, enzyme-inhibitory, and toxic activities of extracts from Adonis ramosa Franch.LinkIT
Guo X, Chen M, He X, Zhao Y, Yu J, Zhu J, Li L, Xia G, Zang H
Natural product research, 2022
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

3.  Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies.LinkIT
Thind M, McKindley DS, Reiffel JA, Naccarelli GV, Stewart J, Kowey PR
Clinical cardiologyClin CardiolPredictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies.10.1002/clc.23768In this post hoc analysis, we assessed patient characteristics as predictors of dronedarone trough concentrations and characterized the relationship of trough concentrations of dronedarone with its efficacy and safety.Dronedarone is recommended as a 400?mg twice daily dose taken orally with meals. We hypothesize that drug concentration/bioavailability of dronedarone, measured as above- and below-median trough concentrations, does not impact the efficacy outcomes.Average trough concentrations (Ctrough_avg ) across multiple timepoints were calculated for each patient, and patient Ctrough_avg values were categorized as below-median or above-median concentrations. The effect of patient baseline characteristics on dronedarone Ctrough_avg was assessed in the below-median versus above-median groups. The effect of dronedarone in each Ctrough_avg group versus placebo on risk of first atrial fibrillation/atrial flutter (AF/AFL) recurrence and safety was also evaluated.Overall, 1795 plasma samples were available from 507 dronedarone-treated patients. An above-median Ctrough_avg was associated with age ?75 years, female sex, lower weight, higher pacemaker use, and higher oral anticoagulant use. The risk of adjudicated first AF/AFL recurrence was significantly lower with dronedarone versus placebo in the below-median (hazard ratio [HR]: 0.71; 95% confidence interval [CI]: 0.56-0.91; p?=?.0054) and above-median groups (HR: 0.63; 95% CI: 0.50-0.81; p?=?.0002). No difference in risk of AF/AFL recurrence was observed between the above- and below-median groups. Safety and tolerability of dronedarone were similar between groups.Significant reduction in AF/AFL recurrence was observed in patients treated with dronedarone versus placebo, regardless of dronedarone concentrations above or below the median value.© 2022 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.ThindMunveerMhttp://orcid.org/0000-0001-9852-2867Division of Cardiology, Lankenau Heart Institute, Wynnewood, Pennsylvania, USA.McKindleyDavid SDSSanofi, Bridgewater, New Jersey, USA.ReiffelJames AJAhttps://orcid.org/0000-0001-5505-1866Division of Cardiology, Columbia University, New York City, New York, USA.NaccarelliGerald VGVhttps://orcid.org/0000-0001-8196-4554Division of Cardiology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.StewartJohnJSanofi, Laval, Quebec, Canada.KoweyPeter RPRhttps://orcid.org/0000-0001-7189-1638Division of Cardiology, Lankenau Heart Institute, Wynnewood, Pennsylvania, USA.engSanofi US Inc.Journal Article20220115United StatesClin Cardiol79032720160-9289IMantiarrhythmic drugatrial fibrillationatrial flutterdronedaronetrough drug concentrations20210831202112132022115832202211660202211660aheadofprint3503213610.1002/clc.23768REFERENCES, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>4.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Toxicity Evaluation of Selected Plant Water Extracts on a Honey Bee (<i>Apis mellifera</i> L.) Larvae Model.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Kruszakin R, Migdal P<br><font color=gray><i>Animals : an open access journal from MDPI, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>5.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Thind M, Zareba W, Atar D, Crijns HJGM, Zhu J, Pak HN, Reiffel J, Ludwigs U, Wieloch M, Stewart J, Kowey P<br><font color=gray><i>Clinical cardiologyClin CardiolEfficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.10.1002/clc.23765The use of antiarrhythmic drugs (AADs) in patients with chronic kidney disease (CKD) is complex because impaired renal clearance can cause increased drug levels, and risk of intolerance or adverse events. Due to the propensity for CKD to occur alongside atrial fibrillation/atrial flutter (AF/AFL), it is essential that AAD safety and efficacy are assessed for patients with CKD.Dronedarone, an approved AAD, may present a suitable therapeutic option for patients with AF/AFL and concomitant CKD.EURIDIS-ADONIS (EURIDIS, NCT00259428; ADONIS, NCT00259376) were identically designed, multicenter, double-blind, parallel-group trials investigating AF/AFL control with dronedarone 400?mg twice daily versus placebo (randomized 2:1). In this post hoc analysis, the primary endpoint was time to first AF/AFL. Patients were stratified according to renal function using the CKD-Epidemiology Collaboration equation and divided into estimated glomerular filtration rate (eGFR) subgroups of 30-44, 45-59, 60-89, and ?90?ml/min. Time-to-events between treatment groups were compared using log-rank testing and Cox regression.At baseline, most (86%) patients demonstrated a mild or mild-to-moderate eGFR decrease. Median time to first AF/AFL recurrence was significantly longer with dronedarone versus placebo for all eGFR subgroups except the 30 to 44 ml/min group, where the trend was similar but statistical power may have been limited by the small population. eGFR stratification had no significant effect on serious adverse events, deaths, or treatment discontinuations.This analysis suggests that dronedarone could be an effective therapeutic option for AF with an acceptable safety profile in patients with impaired renal function.© 2022 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.ThindMunveerMhttp://orcid.org/0000-0001-9852-2867Division of Cardiology, Lankenau Heart Institute, Wynnewood, Pennsylvania, USA.ZarebaWojciechWDivision of Cardiology, University of Rochester Medical Center, Rochester, New York, USA.AtarDanDhttps://orcid.org/0000-0003-1513-8793Department of Cardiology, Oslo University Hospital Ulleval, University of Oslo, Oslo, Norway.CrijnsHarry J G MHJGMhttps://orcid.org/0000-0003-1073-5337Department of Cardiology, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands.ZhuJunJFuwai Hospital, CAMS & PUMC, Beijing, China.PakHui-NamHNhttp://orcid.org/0000-0002-3256-3620Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea.ReiffelJamesJhttps://orcid.org/0000-0001-5505-1866Division of Cardiology, Columbia University Medical Center, New York, New York, USA.LudwigsUlfUhttps://orcid.org/0000-0002-9724-0478Sanofi, Stockholm, Sweden.WielochMattiasMhttps://orcid.org/0000-0002-7425-6549Sanofi, Paris, France.Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.StewartJohnJSanofi, Quebec, Canada.KoweyPeterPhttps://orcid.org/0000-0001-7189-1638Division of Cardiology, Lankenau Heart Institute, Wynnewood, Pennsylvania, USA.engSanofiJournal Article20220112United StatesClin Cardiol79032720160-9289IMantiarrhythmic drugsatrial fibrillation/atrial flutterchronic kidney diseasedronedaronerenal function2021120120210902202112132022112852202211360202211360aheadofprint3501917510.1002/clc.23765REFERENCES, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>6.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Insect Visitors of Black Cherry (Prunus serotina) (Rosales: Rosaceae) and Factors Affecting Viable Seed Production.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>McLaughlin R, Keller J, Wagner E, Biddinger D, Grozinger C, Hoover K<br><font color=gray><i>Environmental entomology, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>7.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>[Spatial and Temporal Distribution of Aerobic Denitrification Bacterial Community in Sediments of Gangnan Reservoir].</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Zhang ZW, Chen ZY, Zhang TN, Zhou SL, Cui JS, Luo X<br><font color=gray><i>Huan jing ke xue= Huanjing kexue, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>8.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Associations of Childhood and Perinatal Blood Metals with Children's Gut Microbiomes in a Canadian Gestation Cohort.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Shen Y, Laue HE, Shrubsole MJ, Wu H, Bloomquist TR, Larouche A, Zhao K, Gao F, Boivin A, Prada D, Hunting DJ, Gillet V, Takser L, Baccarelli AA<br><font color=gray><i>Environmental health perspectives, 2022</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>9.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Essential Oils and Supercritical CO<sub>2</sub> Extracts of Arctic Angelica (<i>Angelica archangelica</i> L.), Marsh Labrador Tea (<i>Rhododendron tomentosum</i>) and Common Tansy (<i>Tanacetum vulgare</i>)-Chemical Compositions and Antimicrobial Activities.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Korpinen RI, Välimaa AL, Liimatainen J, Kunnas S<br><font color=gray><i>Molecules (Basel, Switzerland), 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br>10.  <a href=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0 class=title>Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer system.</a><a href=http://ubio.org/tools/linkit.php?map%5B%5D=all&link_type=2&url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0><img src=linkit.png border=0 title='LinkIT' alt='LinkIT'></a> <br><span class=j>Brooks T, Wayne J, Massey AJ<br><font color=gray><i>Molecular biomedicine, 2021</i></font><br><font color=#008000>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0<br></font></span><br><br><br><table cellspacing=0 cellpadding=0 align=center><tr valign=bottom><td align=center><img src=p.png border=0></td><td align=center><img src=o_red.png border=0></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=2><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=3><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=4><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=5><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=6><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=7><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=8><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=9><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=10><img src=o_yellow.png border=0></a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=2><img src=rtal.png border=0></a></td></tr><td align=center></td><td align=center>1</td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=2>2</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=3>3</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=4>4</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=5>5</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=6>6</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=7>7</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=8>8</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=9>9</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=10>10</a></td><td align=center><a href=http://ubio.org/portal/index.php?search=oxeye+daisy&category=l&client=pubmed&startPage=2>»</a></td></tr></table></table></tr></table></td><script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-634822-1"; urchinTracker(); </script> </BODY> </HTML>